Living cellular constructs for keratinized tissue augmentation: A 13‐year follow‐up from a split‐mouth randomized, controlled, clinical trial
Journal of Periodontology · 2023
DOI: 10.1002/jper.23-0040 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontology, 2023. Verfasst von Lorenzo Tavelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Infection, and Immunity, Division of Periodontology, Harvard School of Dental Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Gingival Recession, Oral Surgical Procedures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, University of Michigan School of Dentistry.
Abstract (Originalsprache)
Background
A 13‐year follow‐up was conducted of a short‐term investigation of the use of living cellular construct (LCC) versus free gingival graft (FGG) for keratinized tissue width (KTW) augmentation in natural dentition, to evaluate the long‐term outcomes and assess the changes occurring since the end of the original 6‐month study.
Methods
Twenty‐four subjects out of the original 29 enrolled participants were available at the 13‐year follow‐up. The primary endpoint was the number of sites demonstrating stable clinical outcomes from 6 months to 13 years (defined as KTW gain, stability, or ≤0.5 mm of KTW loss, together with reduction, stability, or increase of probing depth, and recession depth [REC] ≤0.5 mm). Secondary outcomes included the assessment of KTW, attached gingiva width (AGW), REC, clinical attachment level, esthetics, and patient‐reported outcomes at the 13‐year visit, assessing the changes from baseline to 6 months.
Results
Nine sites per group (42.9%) were found to have maintained stable (≤0.5 mm or improved) clinical outcomes from 6 months to 13 years. No significant differences were observed for the clinical parameters between LCC and FGG from 6 months to 13 years. However, the longitudinal mixed model analysis showed that FGG delivered significantly better clinical outcomes over 13 years ( p < 0.01). LCC‐treated sites exhibited superior esthetic outcomes compared to FGG‐treated sites at 6 months and 13 years ( p < 0.01). Patient‐evaluated esthetics were significantly higher for LCC over FGG ( p < 0.01). Patient overall treatment preference was also in favor of LCC ( p < 0.01).
Conclusions
A similar stability of the treatment outcomes from 6 months to 13 years was found for LCC‐ and FGG‐treated sites, with both approaches shown to be effective in augmenting KTW and AGW. However, superior clinical outcomes were found for FGG over 13 years, while LCC was associated with better esthetics and patient‐reported outcomes than FGG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Medicine, Infection, and Immunity, Division of Periodontology, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
- Department of Periodontics & Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
- Center for Clinical Research and Evidence Synthesis In oral TissuE RegeneratION (CRITERION), Boston, Massachusetts, USA.
- Postgraduate Periodontics, Division of Periodontics, Columbia University College of Dental Medicine, New York City, New York, USA.
- Department of Periodontics, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Shayan Barootchi, William V Giannobile
Förderung
- NCATS NIH HHS
- University of Michigan School of Dentistry
Zitieren
APA
Tavelli, L., Barootchi, S., Rodriguez, M. V., Travan, S., Oh, T. J., Neiva, R., & Giannobile, W. V. (2023). Living cellular constructs for keratinized tissue augmentation: A 13‐year follow‐up from a split‐mouth randomized, controlled, clinical trial. Journal of Periodontology. https://doi.org/10.1002/jper.23-0040
Vancouver
Tavelli L, Barootchi S, Rodriguez MV, Travan S, Oh TJ, Neiva R, et al. Living cellular constructs for keratinized tissue augmentation: A 13‐year follow‐up from a split‐mouth randomized, controlled, clinical trial. Journal of Periodontology. 2023. doi:10.1002/jper.23-0040
BibTeX
@article{Tavelli2023,
author = {Tavelli, Lorenzo and Barootchi, Shayan and Rodriguez, Maria Vera and Travan, Suncica and Oh, Tae-Ju and Neiva, Rodrigo and Giannobile, William V},
title = {Living cellular constructs for keratinized tissue augmentation: A 13‐year follow‐up from a split‐mouth randomized, controlled, clinical trial},
journal = {Journal of Periodontology},
year = {2023},
doi = {10.1002/jper.23-0040}
}
EUVIMED